These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 24451220)

  • 21. Self-reported disability in patients with inflammatory bowel disease largely determined by disease activity and illness perceptions.
    van der Have M; Fidder HH; Leenders M; Kaptein AA; van der Valk ME; van Bodegraven AA; Dijkstra G; de Jong DJ; Pierik M; Ponsioen CY; van der Meulen-de Jong AE; van der Woude CJ; van de Meeberg PC; Romberg-Camps MJ; Clemens CH; Jansen JM; Mahmmod N; Bolwerk CJ; Vermeijden JR; Siersema PD; Oldenburg B; ;
    Inflamm Bowel Dis; 2015 Feb; 21(2):369-77. PubMed ID: 25569738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychological stress and inflammatory bowel disease: a follow-up study in parents who lost a child in Denmark.
    Li J; Nørgard B; Precht DH; Olsen J
    Am J Gastroenterol; 2004 Jun; 99(6):1129-33. PubMed ID: 15180736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Five-year mortality in colorectal cancer patients with ulcerative colitis or Crohn's disease: a nationwide population-based cohort study.
    Ording AG; Horváth-Puhó E; Erichsen R; Long MD; Baron JA; Lash TL; Sørensen HT
    Inflamm Bowel Dis; 2013; 19(4):800-5. PubMed ID: 23435402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic determinants associated with early age of diagnosis of IBD.
    Connelly TM; Berg AS; Harris L; Brinton D; Deiling S; Koltun WA
    Dis Colon Rectum; 2015 Mar; 58(3):321-7. PubMed ID: 25664710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urinary excretion of N-methylhistamine as a marker of disease activity in inflammatory bowel disease.
    Winterkamp S; Weidenhiller M; Otte P; Stolper J; Schwab D; Hahn EG; Raithel M
    Am J Gastroenterol; 2002 Dec; 97(12):3071-7. PubMed ID: 12492192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in inflammatory bowel disease subtype during follow-up and over time in 44,302 patients.
    Everhov ÅH; Sachs MC; Malmborg P; Nordenvall C; Myrelid P; Khalili H; Elmberg M; Ekbom A; Askling J; Jakobsson G; Halfvarson J; Ludvigsson JF; Olén O
    Scand J Gastroenterol; 2019 Jan; 54(1):55-63. PubMed ID: 30700170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of Bariatric Surgery on the Long-term Disease Course of Inflammatory Bowel Disease.
    Braga Neto MB; Gregory MH; Ramos GP; Bazerbachi F; Bruining DH; Abu Dayyeh BK; Kushnir VM; Raffals LE; Ciorba MA; Loftus EV; Deepak P
    Inflamm Bowel Dis; 2020 Jun; 26(7):1089-1097. PubMed ID: 31613968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors associated with disease evolution in Greek patients with inflammatory bowel disease.
    Chatzicostas C; Roussomoustakaki M; Potamianos S; Paspatis G; Mouzas I; Romanos J; Mavrogeni H; Kouroumalis E
    BMC Gastroenterol; 2006 Jul; 6():21. PubMed ID: 16869971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endothelial function and cardiovascular risk in active inflammatory bowel diseases.
    Principi M; Mastrolonardo M; Scicchitano P; Gesualdo M; Sassara M; Guida P; Bucci A; Zito A; Caputo P; Albano F; Ierardi E; Di Leo A; Ciccone MM
    J Crohns Colitis; 2013 Nov; 7(10):e427-33. PubMed ID: 23473915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association Between Long-Term Lipid Profiles and Disease Severity in a Large Cohort of Patients with Inflammatory Bowel Disease.
    Koutroumpakis E; Ramos-Rivers C; Regueiro M; Hashash JG; Barrie A; Swoger J; Baidoo L; Schwartz M; Dunn MA; Koutroubakis IE; Binion DG
    Dig Dis Sci; 2016 Mar; 61(3):865-71. PubMed ID: 26514677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Influence of Antidepressants on the Disease Course Among Patients With Crohn's Disease and Ulcerative Colitis-A Danish Nationwide Register-Based Cohort Study.
    Kristensen MS; Kjærulff TM; Ersbøll AK; Green A; Hallas J; Thygesen LC
    Inflamm Bowel Dis; 2019 Apr; 25(5):886-893. PubMed ID: 30551218
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bi-directionality of Brain-Gut Interactions in Patients With Inflammatory Bowel Disease.
    Gracie DJ; Guthrie EA; Hamlin PJ; Ford AC
    Gastroenterology; 2018 May; 154(6):1635-1646.e3. PubMed ID: 29366841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Finger clubbing in inflammatory bowel disease: association with upper small bowel lesions and need of surgery in Crohn's disease.
    Romeo S; Neri B; Mossa M; Calabrese E; Lolli E; Sena G; Gesuale C; Chiaramonte C; Biancone L
    Eur J Gastroenterol Hepatol; 2021 Jun; 33(6):844-851. PubMed ID: 33136723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Effects of Active IBD During Pregnancy in the Era of Novel IBD Therapies.
    de Lima-Karagiannis A; Zelinkova-Detkova Z; van der Woude CJ
    Am J Gastroenterol; 2016 Sep; 111(9):1305-12. PubMed ID: 27349339
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of an Inflammatory Bowel Disease Research Registry Derived from Observational Electronic Health Record Data for Comprehensive Clinical Phenotyping.
    Anderson AJ; Click B; Ramos-Rivers C; Babichenko D; Koutroubakis IE; Hartman DJ; Hashash JG; Schwartz M; Swoger J; Barrie AM; Dunn MA; Regueiro M; Binion DG
    Dig Dis Sci; 2016 Nov; 61(11):3236-3245. PubMed ID: 27619390
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Change of diagnosis during the first five years after onset of inflammatory bowel disease: results of a prospective follow-up study (the IBSEN Study).
    Henriksen M; Jahnsen J; Lygren I; Sauar J; Schulz T; Stray N; Vatn MH; Moum B;
    Scand J Gastroenterol; 2006 Sep; 41(9):1037-43. PubMed ID: 16938716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Helminth therapy (worms) for induction of remission in inflammatory bowel disease.
    Garg SK; Croft AM; Bager P
    Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD009400. PubMed ID: 24442917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impaired Intestinal Permeability Contributes to Ongoing Bowel Symptoms in Patients With Inflammatory Bowel Disease and Mucosal Healing.
    Chang J; Leong RW; Wasinger VC; Ip M; Yang M; Phan TG
    Gastroenterology; 2017 Sep; 153(3):723-731.e1. PubMed ID: 28601482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of obesity on disease activity and disease outcome in inflammatory bowel disease: Results from the Swiss inflammatory bowel disease cohort.
    Greuter T; Porchet F; Braga-Neto MB; Rossel JB; Biedermann L; Schreiner P; Scharl M; Schoepfer AM; Safroneeva E; Straumann A; Rogler G; Vavricka SR
    United European Gastroenterol J; 2020 Dec; 8(10):1196-1207. PubMed ID: 33276710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of Small Intestinal Transit Times in Ulcerative Colitis and Crohn's Disease Patients with Different Disease Activity Using Video Capsule Endoscopy.
    Fischer M; Siva S; Wo JM; Fadda HM
    AAPS PharmSciTech; 2017 Feb; 18(2):404-409. PubMed ID: 27032935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.